Japan Fortnightly Update: Turning Point
TURNING POINT - Despite the last four trading days being 'up', the Japanese equity market composite fell by 0.6% over the last two weeks. New...
606 Views
Japan: Scoring Results & Forecasts - Part 3 - Company Winners & Losers
INTRODUCTION - The final part of our Results and Forecast/Revision Scores review will look at the leading and lagging performers and forecasters...
482 Views
SanBio Co Ltd (4592 JP): Akuugo Approval Awaited; Plans Negotiation for Ischemic Stroke Trials
SanBio revised FY26 operating loss guidance to reflect higher manufacturing expenses to secure the inventory necessary for future clinical trials...
396 Views
SanBio Co Ltd (4592 JP): 1H FY01/26 flash update
In 1H FY01/26, the company reported no operating revenue, with an operating loss of JPY1.9bn and R&D expenses increasing by 31.5%...
462 Views
SanBio Co Ltd (4592 JP): Akuugo Shipments Expected To Commence In 2QFY26, New Credit Line In Place
SanBio reports Q1FY26 result. Higher R&D expenses (¥ 723M) and foreign exchange losses (¥ 711M) led to a net loss of ¥ 1,531M (vs ¥ 144M in...
1.1k Views